Poly Medicure Limited

BSE:531768 Stock Report

Market Cap: ₹263.2b

Poly Medicure Management

Management criteria checks 2/4

Poly Medicure's CEO is Himanshu Baid, appointed in Sep 1995, has a tenure of 29.25 years. total yearly compensation is ₹171.78M, comprised of 33.6% salary and 66.4% bonuses, including company stock and options. directly owns 11.59% of the company’s shares, worth ₹30.52B. The average tenure of the management team and the board of directors is 6.5 years and 8.5 years respectively.

Key information

Himanshu Baid

Chief executive officer

₹171.8m

Total compensation

CEO salary percentage33.6%
CEO tenure29.3yrs
CEO ownership11.6%
Management average tenure6.5yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Himanshu Baid's remuneration changed compared to Poly Medicure's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹3b

Jun 30 2024n/an/a

₹3b

Mar 31 2024₹172m₹58m

₹3b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹130m₹55m

₹2b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹1b

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹107m₹49m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹92m₹44m

₹1b

Dec 31 2020n/an/a

₹1b

Sep 30 2020n/an/a

₹1b

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹62m₹35m

₹959m

Dec 31 2019n/an/a

₹947m

Sep 30 2019n/an/a

₹858m

Jun 30 2019n/an/a

₹719m

Mar 31 2019₹44m₹14m

₹654m

Mar 31 2018₹41m₹14m

₹706m

Compensation vs Market: Himanshu's total compensation ($USD2.02M) is above average for companies of similar size in the Indian market ($USD582.59K).

Compensation vs Earnings: Himanshu's compensation has increased by more than 20% in the past year.


CEO

Himanshu Baid (56 yo)

29.3yrs

Tenure

₹171,781,000

Compensation

Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...


Leadership Team

NamePositionTenureCompensationOwnership
Himanshu Baid
CEO, MD & Director29.3yrs₹171.78m11.59%
₹ 30.5b
Jugal Baid
Founder & Non Executive Directorno data₹1.43m2.25%
₹ 5.9b
Naresh Vijayvergiya
Chief Financial Officer3.4yrs₹11.21mno data
Avinash Chandra
Company Secretary & Compliance Officer9.6yrs₹1.88mno data
Rishi Baid
Joint MD & Executive Directorno data₹166.82m12.38%
₹ 32.6b
Vishal Baid
President of Corporate Sales & Marketing2.7yrs₹18.39m1.66%
₹ 4.4b
P. Rastogi
Assistant Vice President of Finance & Accountsno datano datano data
Hemant Bhalla
Senior Vice President of Domestic Sales & Marketingno data₹5.79mno data
Pankaj Gupta
President of R&Dno data₹5.61mno data
Manish Sardana
President of Sales & Marketing - Indiano data₹8.61mno data

6.5yrs

Average Tenure

56yo

Average Age

Experienced Management: 531768's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Himanshu Baid
CEO, MD & Director29.8yrs₹171.78m11.59%
₹ 30.5b
Jugal Baid
Founder & Non Executive Director29.8yrs₹1.43m2.25%
₹ 5.9b
Rishi Baid
Joint MD & Executive Director29.8yrs₹166.82m12.38%
₹ 32.6b
Vimal Bhandari
Non-Executive Independent Directorless than a yearno datano data
Amit Khosla
Non-Executive Independent Director4.5yrs₹1.60mno data
Devendra Mehta
Non-Executive Independent Chairman19.6yrs₹1.63mno data
Mukulika Baid
Non-Executive Director10.4yrs₹1.43m3.02%
₹ 8.0b
Sonal Mattoo
Non-Executive Independent Director4.3yrs₹1.45mno data
Alessandro Balboni
Non-Executive Non Independent Director6.6yrs₹29.90mno data
Ambrish Mithal
Independent Director2.7yrs₹1.45mno data

8.5yrs

Average Tenure

64.5yo

Average Age

Experienced Board: 531768's board of directors are considered experienced (8.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 18:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Poly Medicure Limited is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Karan KhannaAmbit Capital
Sunita VaidyanathanBrics Securities Limited